Loading...
Target Audience: Gastroenterologists, primary care providers
The previous guideline on screening for colorectal cancer (CRC) from the MSTF was published in 2008. Recent evidence was identified, graded, and incorporated into the new document.
Older screening modalities like barium enema have been removed. Newer approaches, such as capsule colonoscopy have been incorporated. Screening tests have been divided into three tiers based upon their effectiveness. Timing of initial screening and intervals for different risk populations are suggested. The time to discontinue screening is discussed. Quality measures are also suggested.
Tier 1
Colonoscopy every 10 years
Annual fecal immunochemical test (FIT)
Tier 2
Computed tomographic colonography every 5 years
FIT–fecal DNA every 3 years
Flexible sigmoidoscopy every 5–10 years
Tier 3
Capsule colonoscopy every 5 years
Not Recommended
Septin 9
Patients at average risk: Tier 1 test beginning at age 50 for non–African-Americans and at age 45 for African-Americans
Patients with one first-degree relative with CRC or advanced adenoma (AA) diagnosed at age <60 or two first-degree relatives with CRC or AA (diagnosed at any age): Colonoscopy at 10 years younger than the youngest age at diagnosis of a first-degree relative, or age 40, to be repeated every 5 years
Patients with one first-degree relative with CRC, AA, or advanced serrated lesion at age ≥60: Tier 1 screening test at age 40 with same intervals as average-risk patients
Patients aged ≥75 with prior negative screening tests or whose life expectancy is less than 10 years (or those aged ≥85 without prior screening): Discontinue colonoscopy screening
Rex DK et al. Colorectal Cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2017 Jun 6; [e-pub]. (http://dx.doi.org/10.1038/ajg.2017.174)
Comment
The data-driven recommendations in this guideline suggest that colonoscopy every 10 years or FIT testing annually should be the screening modality in most patients. Patients with an elevated risk for CRC should start screening earlier, and colonoscopy is the preferred approach in patients with a strong family history.